Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-03 Sale |
2023-03-07 4:44 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
6,256 | $9.71 | $60,746 | 93,527 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-07 4:43 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
6,221 | $9.71 | $60,406 | 58,885 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 4:27 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
2,265 | $10.2 | $23,103 | 65,106 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 6:38 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
4,191 | $11.8 | $49,454 | 182,370 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 4:18 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
2,265 | $10.81 | $24,485 | 67,371 (Direct) |
View |
| 2022-12-29 Sale |
2023-01-03 4:32 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
2,265 | $10.18 | $23,058 | 69,636 (Direct) |
View |
| 2022-12-21 Sale |
2022-12-23 4:54 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
3,506 | $11.27 | $39,513 | 166,275 (Direct) |
View |
| 2022-12-21 Sale |
2022-12-23 4:53 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
2,992 | $11.27 | $33,720 | 71,901 (Direct) |
View |
| 2022-12-21 Sale |
2022-12-23 4:52 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
2,561 | $11.27 | $28,862 | 99,783 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 5:23 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
14,470 | $11.13 | $161,051 | 186,561 (Direct) |
View |
| 2022-09-14 Sale |
2022-09-16 4:21 pm |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
10,800 | $10.28 | $111,024 | 44,988 (Direct) |
View |
| 2022-07-15 Sale |
2022-07-19 5:16 pm |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
3,600 | $9.05 | $32,580 | 15,476 (Direct) |
View |
| 2022-07-15 Sale |
2022-07-19 5:13 pm |
Cara Therapeutics Inc. | CARA | BAINS HARRISON M JR Director |
7,200 | $9.05 | $65,160 | 25,076 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 5:51 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
1,642 | $11.91 | $19,556 | 102,344 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 5:50 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
1,642 | $11.91 | $19,556 | 74,893 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 5:49 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
1,784 | $11.91 | $21,247 | 169,781 (Direct) |
View |
| 2022-04-04 Sale |
2022-04-05 5:48 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
2,006 | $12.67 | $25,416 | 201,031 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-04 5:54 pm |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
2,044 | $11.38 | $23,261 | 37,811 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-04 5:51 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
1,787 | $11.38 | $20,336 | 103,986 (Direct) |
View |
| 2022-02-25 Sale |
2022-03-01 4:19 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
1,972 | $10.29 | $20,292 | 145,773 (Direct) |
View |
| 2022-02-25 Sale |
2022-03-01 4:16 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
2,114 | $10.29 | $21,753 | 211,565 (Direct) |
View |
| 2022-02-25 Sale |
2022-03-01 4:14 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
1,972 | $10.29 | $20,292 | 156,535 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-01 Option Award |
2023-03-03 4:38 pm |
N/A 2033-03-01 |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
81,000 | $0 | 81,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:38 pm |
N/A 2033-03-01 |
Cara Therapeutics Inc. | CARA | Maynard Ryan D Chief Financial Officer |
81,000 | $0 | 81,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:37 pm |
N/A 2033-03-01 |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
81,000 | $0 | 81,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:36 pm |
N/A 2033-03-01 |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
81,000 | $0 | 81,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 4:35 pm |
N/A 2033-03-01 |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-01-02 Option Award |
2023-01-19 5:49 pm |
N/A 2033-01-02 |
Cara Therapeutics Inc. | CARA | von Moltke Lisa Director |
45,841 | $0 | 45,841 (Direct) |
View |
| 2022-09-12 Option Award |
2022-09-14 4:42 pm |
N/A 2032-09-12 |
Cara Therapeutics Inc. | CARA | Maynard Ryan D Chief Financial Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:14 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Makara Richard VP, Head of Accting;Controller |
7,500 | $0 | 13,583 (Direct) |
View |
Ownership |
2022-06-16 5:12 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Makara Richard VP, Head of Accting;Controller |
0 | $0 | 176,083 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:52 pm |
N/A 2032-06-02 |
Cara Therapeutics Inc. | CARA | Shiff Susan Ph.D. Director |
28,872 | $0 | 36,072 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:51 pm |
N/A 2032-06-02 |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
28,872 | $0 | 36,072 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:50 pm |
N/A 2032-06-02 |
Cara Therapeutics Inc. | CARA | BAINS HARRISON M JR Director |
28,872 | $0 | 49,272 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:49 pm |
N/A 2032-06-02 |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
69,621 | $0 | 89,781 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 4:19 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
65,333 | $0 | 145,773 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-01 4:18 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
5,333 | $10.29 | 79,855 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 4:18 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
60,000 | $0 | 79,855 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 4:17 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
160,000 | $0 | 324,037 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 4:16 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
60,000 | $0 | 211,565 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 4:14 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
100,000 | $0 | 156,535 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 5:32 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
12,607 | $0 | 153,679 (Direct) |
View |